Colorectal cancer (CRC) is a most common and lethal disease of the gastrointestinal tract [1]. CRC can usually spread by lymphatic and hematogenous routes. The most common metastatic sites are the regional lymph nodes, liver, lungs, and peritoneum [1]. Uncommon metastasis of CRC were described such as skin, muscles, skull and thyroid [2][3] [4] [5] [6] . Involvement of unusual sites with metastasis frequently occurs in the presence disseminated disease. Thus, the patient presented with widespread metastasis had poor prognosis [4] . Although all types of tumors lead to metastasis to skull hematogenous route, breast cancer and lung cancers are associated with the highest rate, skull metastases of CRC are quite rare [5] . Parietal bone metastasis without vertebral bone metastasis from CRC is an unexpected situation. The most common presenting symptom of skull metastases is a visible, localized swelling of skull produced by growing tumor [7] . Herein, we report a case of patient with a visible, localized swelling of skull.
Introduction
Volume 1 | Issue 1 ScholArena | www.scholarena.com
SAJ Case Reports ISSN: 2375-7043
Case report CRC is a most common disease of the gastrointestinal tract and the second most common type of primary cancer in both and women in the world [8, 9] . The most common metastatic sites are the regional lymph nodes and visceral organs. Bone metastases typically occurs with other visceral organ metastasis. The most common metastatic bone lesions are shoulder, pelvis, femur and vertebral column. The average time of metastasis is approximately two years after primary tumour rejection. Five-year survival rates of metastatic rectal adenocarcinoma is approximately 6% [1,10].
Skeletal metastases with colorectal cancer occur in 5-10% of cases and usually after widespread metastatic disease. The most likely route for skeletal seeding is through Batson's plexus, a valveless system of veins draining to the vertebral column. The usual pattern of metastasis is through the liver and lungs, thus making isolated skeletal metastases uncommon, at 1 -2%. [5, 11, 12] . The other unusual metastatic site is skull [5] . Although surgical excision of unusual metastasis such as skin, skull, scapula of colorectal cancer cannot influence the course of the underlying disease, the mean survival time and morbidity can be improved by surgery [12] [13] [14] .
Onesti et al. reported scapula metastasis of CRC. The patient treated with chemoradiotherapy followed by chemotherapy with infusional 5-fluorouracil, leucovorin, oxaliplatin and bevacizumab (FOLFOX-BEV). After 12 cycles, the because of developing side effects, the regimen has changed to FOLFIRI. After chemotherapy, the patient underwent surgery [12] .
Fahrtash et al. reported a cervical metastases of colorectal cancer with pathological fracture as an initial diagnosis. Palliative radiotherapy to the cervical spine in 10 fractions of 30 Gy has performed. After palliative radiotherapy, FOLFOX chemo regimen had started [15] .
In this case, we present a parietal bone metastasis of rectal adenocarcinoma as an initial diagnosis of recurrence without vertebral bone metastasis after approximately 3 years. The rectal adenocarcinoma of this patient was diagnosed in 2009. Neoadjuvant chemoradiotherapy, low anterior resection and adjuvant had performed. He was followed-up until 2012 asymptomatically. He presented with a visible, localized, round subcutaneous nodules. This symptom is also most common symptom of the patient with presenting skull metastasis [7] . To date, only a few metastatic adenocarcinoma of gastrointestinal tract tumours to skull had been reported [5, 16, 17] .
